Planned Upgrades Expected to Reduce Natural Gas Use, Lower Carbon Intensity of Biofuel, and Decrease Operating Costs by $13 Million Per Year CUPERTINO, CA, Jan. 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aemetis, Inc. (AMTX) (“Aemetis”) announced today that its subsidiary Aemetis Advanced Fuels Keyes, Inc. has received from the California Energy… Read More..

Soligenix is actively enrolling patients in a Phase 3 multinational, double-blind, placebo-controlled clinical trial of SGX942, or dusquetide, for the treatment of oral mucositis in patients with head and neck cancer (HNC) receiving chemoradiation therapy (CRT). Since enrolling its first patent in December 2017 in a controlled rollout of the study… Read More..

SOUTH ORANGE, NJ, January 27, 2020 Dear Friends and Shareholders, With the turn of the new year, we are writing to provide a comprehensive update about Nephros and our plans for the future. In the two years since our last shareholder letter, we have grown revenues over 200%, redesigned our… Read More..